Ji Yun Lee

2.9k total citations
105 papers, 1.9k citations indexed

About

Ji Yun Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Ji Yun Lee has authored 105 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 26 papers in Hematology. Recurrent topics in Ji Yun Lee's work include Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Ji Yun Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (11 papers) and Gastric Cancer Management and Outcomes (9 papers). Ji Yun Lee collaborates with scholars based in South Korea, United States and Puerto Rico. Ji Yun Lee's co-authors include Sung Hee Lim, Keunchil Park, Myung‐Ju Ahn, Soo‐Mee Bang, Jong‐Mu Sun, Jeong‐Ok Lee, Jin Seok Ahn, Hae Su Kim, Se‐Hoon Lee and P. K. Sharkey and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ji Yun Lee

97 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Yun Lee South Korea 24 708 662 437 321 289 105 1.9k
Tadashi Mio Japan 33 1.7k 2.5× 1.9k 2.9× 653 1.5× 392 1.2× 364 1.3× 156 3.8k
Rasim Gucalp United States 24 1.1k 1.5× 628 0.9× 269 0.6× 187 0.6× 116 0.4× 87 1.7k
Seung Ick South Korea 25 374 0.5× 976 1.5× 626 1.4× 440 1.4× 288 1.0× 181 2.2k
Lisa Derosa France 25 1.7k 2.5× 1.0k 1.5× 1.3k 3.1× 184 0.6× 415 1.4× 111 3.2k
Jae Berm Park South Korea 27 531 0.8× 459 0.7× 308 0.7× 540 1.7× 176 0.6× 204 2.5k
Michael Cullen United Kingdom 18 964 1.4× 487 0.7× 248 0.6× 226 0.7× 116 0.4× 42 1.4k
Antonio Ghidini Italy 27 1.4k 2.0× 695 1.0× 435 1.0× 249 0.8× 362 1.3× 91 2.3k
Guglielmo Nasti Italy 32 1.7k 2.4× 427 0.6× 386 0.9× 441 1.4× 222 0.8× 154 3.1k
Yu Yang Soon Singapore 22 795 1.1× 882 1.3× 207 0.5× 157 0.5× 133 0.5× 86 2.0k
Montserrat Fraga Switzerland 15 1.4k 1.9× 405 0.6× 290 0.7× 366 1.1× 86 0.3× 51 2.3k

Countries citing papers authored by Ji Yun Lee

Since Specialization
Citations

This map shows the geographic impact of Ji Yun Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Yun Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Yun Lee more than expected).

Fields of papers citing papers by Ji Yun Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Yun Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Yun Lee. The network helps show where Ji Yun Lee may publish in the future.

Co-authorship network of co-authors of Ji Yun Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Yun Lee. A scholar is included among the top collaborators of Ji Yun Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Yun Lee. Ji Yun Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ji Yun, Sung‐Soo Yoon, Deok‐Hwan Yang, et al.. (2025). Efficacy and Safety of Ropeginterferon Alfa-2b in Low-Risk Polycythemia Vera. Cancer Research and Treatment. 1 indexed citations
2.
3.
Kim, Se Hyun, Sejoon Lee, Min-Su Kang, et al.. (2024). Association of TP53 Mutation Status and Sex with Clinical Outcome in Non–Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study. Cancer Research and Treatment. 57(1). 70–82. 1 indexed citations
4.
Lee, Ji Yun, Ju Hyun Lee, Min-Su Kang, et al.. (2024). Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study. Journal of Korean Medical Science. 39(22). e175–e175. 1 indexed citations
5.
Kim, Seokhyeon, Ja Min Byun, Junshik Hong, et al.. (2024). Phase II trial of imatinib mesylate in patients with PDGFRA/B ‐negative hypereosinophilic syndrome. British Journal of Haematology. 205(6). 2305–2314. 2 indexed citations
6.
Seo, Soo Hyun, Jin-Ho Kim, Ji Yun Lee, et al.. (2024). Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience. Molecular Diagnosis & Therapy. 28(3). 311–318. 2 indexed citations
7.
Lee, Ji Yun, Ji Hyun Kwon, Joon Young Hur, et al.. (2023). Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea. Cancer Research and Treatment. 56(2). 681–687. 4 indexed citations
8.
Kim, Mihee, Je‐Jung Lee, Chang‐Ki Min, et al.. (2023). Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Annals of Hematology. 102(8). 2233–2240. 1 indexed citations
9.
Kwon, Byoung Soo, et al.. (2022). Interstitial pneumonitis associated with dasatinib treatment for chronic myeloid leukemia or acute lymphoblastic leukemia: case series and a literature review. Therapeutic Advances in Respiratory Disease. 16. 2673714650–2673714650.
10.
Jung, Eun Hee, Yu Jung Kim, Beodeul Kang, et al.. (2022). Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center. JCO Oncology Practice. 18(10). e1661–e1671. 8 indexed citations
11.
Kim, Se Hyun, Eun Hee Jung, Koung Jin Suh, et al.. (2022). The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors. Thoracic Cancer. 14(1). 52–60. 13 indexed citations
12.
Lee, Ji Yun, Joo Hyun Kim, Heejin Bang, et al.. (2021). EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma. Scientific Reports. 11(1). 10342–10342. 8 indexed citations
13.
Lee, Ji Yun, Min-Su Kang, Koung Jin Suh, et al.. (2020). Pneumocystis jirovecii pneumonia in diffuse large B‐cell Lymphoma treated with R‐CHOP. Mycoses. 64(1). 60–65. 8 indexed citations
14.
Kim, Kui‐Jin, Ji‐Won Kim, Koung Jin Suh, et al.. (2020). PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer. Scientific Reports. 10(1). 12308–12308. 25 indexed citations
15.
Kwon, Jihyun, Kui‐Jin Kim, Koung Jin Suh, et al.. (2019). Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement. Cells. 8(12). 1538–1538. 9 indexed citations
16.
Choi, In Sil, Jee Hyun Kim, Ju Hyun Lee, et al.. (2018). A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study. PLoS ONE. 13(10). e0205853–e0205853. 8 indexed citations
17.
Kim, Se Hyun, Chan-Young Ock, Koung Jin Suh, et al.. (2018). BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression. International Journal of Molecular Sciences. 19(10). 3164–3164. 17 indexed citations
18.
Lee, Min‐Young, Bo Mi Ku, Hae Su Kim, et al.. (2016). Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer. Cancer Research and Treatment. 49(4). 906–914. 21 indexed citations
19.
Lee, Ji Yun, Jong‐Mu Sun, Sung Hee Lim, et al.. (2015). A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. Clinical Cancer Research. 22(9). 2139–2145. 28 indexed citations
20.
Lee, Ji Yun, Min Eui Hong, Seung Tae Kim, et al.. (2015). The Impact of Concomitant Genomic Alterations on Treatment Outcome for Trastuzumab Therapy in HER2-Positive Gastric Cancer. Scientific Reports. 5(1). 9289–9289. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadashi Mio Breakdown of academic impact, for papers by Rasim Gucalp Breakdown of academic impact, for papers by Seung Ick Breakdown of academic impact, for papers by Lisa Derosa Breakdown of academic impact, for papers by Jae Berm Park Breakdown of academic impact, for papers by Michael Cullen Breakdown of academic impact, for papers by Antonio Ghidini Breakdown of academic impact, for papers by Guglielmo Nasti Breakdown of academic impact, for papers by Yu Yang Soon Breakdown of academic impact, for papers by Montserrat Fraga
Rankless by CCL
2026